Bordetella adenylate cyclase toxin is a unique ligand of the integrin complement receptor 3

eLife

Volumn 4, Issue DECEMBER2015, 2015, Pages

  Osicka, Radim ^a   Osickova, Adriana ^a,b   Hasan, Shakir ^a   Bumba, Ladislav ^a   Cerny, Jiri ^c   Sebo, Peter ^a  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c INSTITUTE OF BIOTECHNOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE TOXIN; CD11B ANTIGEN; CD18 ANTIGEN; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 3; CYCLIC AMP; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN G1; INTEGRIN; LIGAND; MONOCLONAL ANTIBODY; PROTEIN KINASE SYK; UNCLASSIFIED DRUG; VIRULENCE FACTOR; PROTEIN BINDING;

ADENYLATE CYCLASE GENE; ANIMAL CELL; ARTICLE; BIOASSAY; BORDETELLA PERTUSSIS; CAMP ASSAY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SUBSTRATE COMPLEX; GENE; GENETIC TRANSFECTION; HAMSTER; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIGAND BINDING; MONOCYTE; MOUSE; NONHUMAN; OVARY CELL; PATHOGENESIS; PLASMID; POLYMERASE CHAIN REACTION; RAT; SURFACE PLASMON RESONANCE; WESTERN BLOTTING; ANIMAL; CELL LINE; HOST PATHOGEN INTERACTION; METABOLISM; PATHOGENICITY;

ADENYLATE CYCLASE TOXIN; ANIMALS; BORDETELLA PERTUSSIS; CELL LINE; CRICETINAE; HOST-PATHOGEN INTERACTIONS; HUMANS; MACROPHAGE-1 ANTIGEN; PROTEIN BINDING;

EID: 84956885724     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.10766     Document Type: Article

References (83)

1. Altieri DC. 1991. Occupancy of CD11b/CD18 (mac-1) divalent ion binding site(s) induces leukocyte adhesion. Journal of Immunology 147:1891-1898.
2. Anthis NJ, Campbell ID. 2011. The tail of integrin activation. Trends in Biochemical Sciences 36:191-198. doi: 10.1016/j.tibs.2010.11.002.
3. Arnaout MA. 1990. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 75:1037-1050.
4. Bagley KC, Abdelwahab SF, Tuskan RG, Fouts TR, Lewis GK. 2002. Pertussis toxin and the adenylate cyclase toxin from bordetella pertussis activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cAMP-dependent pathway. Journal of Leukocyte Biology 72:962-969.
5. Benada O, Pokorný V. 1990. Modification of the polaron sputter-coater unit for glow-discharge activation of carbon support films. Journal of Electron Microscopy Technique 16:235-239. doi: 10.1002/jemt.1060160304.
6. Boschwitz JS, Batanghari JW, Kedem H, Relman DA. 1997. Bordetella pertussis infection of human monocytes inhibits antigen-dependent CD4 t cell proliferation. The Journal of Infectious Diseases 176:678-686. doi: 10.1086/514090.
7. Boyd AP, Ross PJ, Conroy H, Mahon N, Lavelle EC, Mills KHG. 2005. Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death. The Journal of Immunology 175:730-738. doi: 10.4049/jimmunol.175.2.730.
8. Caron E, Hall A. 1998. Identification of two distinct mechanisms of phagocytosis controlled by different rho GTPases. Science 282:1717-1721. doi: 10.1126/science.282.5394.1717.
9. Cerny O, Kamanova J, Masin J, Bibova I, Skopova K, Sebo P. 2015. Bordetella pertussis adenylate cyclase toxin blocks induction of bactericidal nitric oxide in macrophages through cAMP-dependent activation of the SHP-1 phosphatase. The Journal of Immunology 194:4901-4913. doi: 10.4049/jimmunol.1402941.
10. Cherry JD. 2012. Why do pertussis vaccines fail? PEDIATRICS 129:968-970. doi: 10.1542/peds.2011-2594.
11. Chothia C, Jones EY. 1997. THE MOLECULAR STRUCTURE of CELL ADHESION MOLECULES. Annual Review of Biochemistry 66:823-862. doi: 10.1146/annurev.biochem.66.1.823.
12. Comeau SR, Kozakov D, Brenke R, Shen Y, Beglov D, Vajda S. 2007. ClusPro: performance in CAPRI rounds 6-11 and the new server. Proteins: Structure, Function, and Bioinformatics 69:781-785. doi: 10.1002/prot.21795.
13. Confer D, Eaton J. 1982. Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science 217: 948-950. doi: 10.1126/science.6287574.
14. Crowley MT, Costello PS, Fitzer-Attas CJ, Turner M, Meng F, Lowell C, Tybulewicz VLJ, DeFranco AL. 1997. A critical role for syk in signal transduction and phagocytosis mediated by fc receptors on macrophages. Journal of Experimental Medicine 186:1027-1039. doi: 10.1084/jem.186.7.1027.
15. Diamond MS, Springer TA. 1993. A subpopulation of mac-1 (cD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. The Journal of Cell Biology 120:545-556. doi: 10.1083/jcb.120.2.545.
16. Drbal K, Angelisová P, Černý J, Hilgert I, Hořejší V. 2001. A novel anti-CD 18 mAb recognizes an activation- related epitope and induces a high-affinity conformation in leukocyte integrins. Immunobiology 203:687-698.doi: 10.1016/S0171-2985(01)80017-6.
17. Eastman P, Pande V. 2010. OpenMM: a hardware-independent framework for molecular simulations. Computing in Science & Engineering 12:34-39. doi: 10.1109/MCSE.2010.27.
18. Eby JC, Gray MC, Warfel JM, Paddock CD, Jones TF, Day SR, Bowden J, Poulter MD, Donato GM, Merkel TJ, Hewlett EL. 2013. Quantification of the adenylate cyclase toxin of bordetella pertussis in vitro and during respiratory infection. Infection and Immunity 81:1390-1398. doi: 10.1128/IAI.00110-13.
19. El-Azami-El-Idrissi M, Bauche C, Loucka J, Osicka R, Sebo P, Ladant D, Leclerc C. 2003. Interaction of bordetella pertussis adenylate cyclase with CD11b/CD18. Journal of Biological Chemistry 278:38514-38521. doi: 10.1074/jbc.M304387200.
20. Eswar N, John B, Mirkovic N, Fiser A, Ilyin VA, Pieper U, Stuart AC, Marti-Renom MA, Madhusudhan MS, Yerkovich B, Sali A. 2003. Tools for comparative protein structure modeling and analysis. Nucleic Acids Research 31:3375-3380. doi: 10.1093/nar/gkg543.
21. Fedele G, Spensieri F, Palazzo R, Nasso M, Cheung GYC, Coote JG, Ausiello CM. 2010. Bordetella pertussis commits human dendritic cells to promote a Th1/Th17 response through the activity of adenylate cyclase toxin and MAPK-pathways. PLoS ONE 5:e8734. doi: 10.1371/journal.pone.0008734.
22. Forsberg M, Lofgren R, Zheng L, Stendahl O. 2001. Tumour necrosis factor-alpha potentiates CR3-induced respiratory burst by activating p38 MAP kinase in human neutrophils. Immunology 103:465-472. doi: 10.1046/j.1365-2567.2001.01270.x.
23. Franken KL, Hiemstra HS, van Meijgaarden KE, Subronto Y, den Hartigh J, Ottenhoff TH, Drijfhout JW. 2000. Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent. Protein Expression and Purification 18:95-99. doi: 10.1006/prep.1999.1162.
24. Friedman RL, Fiederlein RL, Glasser L, Galgiani JN. 1987. Bordetella pertussis adenylate cyclase: effects of affinity-purified adenylate cyclase on human polymorphonuclear leukocyte functions. Infection and Immunity 55:135-140.
25. Friedrichs MS, Eastman P, Vaidyanathan V, Houston M, Legrand S, Beberg AL, Ensign DL, Bruns CM, Pande VS. 2009. Accelerating molecular dynamic simulation on graphics processing units. Journal of Computational Chemistry 30:864-872. doi: 10.1002/jcc.21209.
26. Gevrey J-C, Isaac BM, Cox D. 2005. Syk is required for Monocyte/Macrophage chemotaxis to CX3CL1 (fractalkine). The Journal of Immunology 175:3737-3745. doi: 10.4049/jimmunol.175.6.3737.
27. Goodwin MS, Weiss AA. 1990. Adenylate cyclase toxin is critical for colonization and pertussis toxin is critical for lethal infection by bordetella pertussis in infant mice. Infection and Immunity 58:3445-3447.
28. Guermonprez P, Khelef N, Blouin E, Rieu P, Ricciardi-Castagnoli P, Guiso N, Ladant D, Leclerc C. 2001. The adenylate cyclase toxin of bordetella pertussis binds to target cells via the m 2 integrin (cd11b/Cd18). Journal of Experimental Medicine 193:1035-1044. doi: 10.1084/jem.193.9.1035.
29. Hasan S, Osickova A, Bumba L, Novák P, Sebo P, Osicka R. 2015. Interaction of bordetella adenylate cyclase toxin with complement receptor 3 involves multivalent glycan binding. FEBS Letters 589:374-379. doi: 10.1016/j.febslet.2014.12.023.
30. Hickey FB, Brereton CF, Mills KHG. 2008. Adenylate cycalse toxin of bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells. Journal of Leukocyte Biology 84:234-243. doi: 10.1189/jlb.0208113.
31. Huang C, Springer TA. 1997. Folding of the -propeller domain of the integrin l subunit is independent of the i domain and dependent on the 2 subunit. Proceedings of the National Academy of Sciences 94:3162-3167. doi:10.1073/pnas.94.7.3162.
32. Huang ZY, Hunter S, Kim MK, Indik ZK, Schreiber AD. 2003. The effect of phosphatases SHP-1 and SHIP-1 on signaling by the ITIM- and ITAM-containing fcgamma receptors FcgammaRIIB and FcgammaRIIA. Journal of Leukocyte Biology 73:823-829. doi: 10.1189/jlb.0902454.
33. Ingalls RR, Arnaout MA, Delude RL, Flaherty S, Savedra R, Golenbock DT. 1998. The CD11/CD18 integrins: characterization of three novel LPS signaling receptors. Progress in Clinical and Biological Research 397:107-117.
34. Jakus Z, Fodor S, Abram CL, Lowell CA, Mócsai A. 2007. Immunoreceptor-like signaling by b2 and b3 integrins. Trends in Cell Biology 17:493-501. doi: 10.1016/j.tcb.2007.09.001.
35. Johnson MS, Chouhan BS. 2014. Evolution of integrin i domains. Adv Exp Med Biol 819:1-19. doi: 10.1007/978-94-017-9153-3-1.
36. Kamanova J, Kofronova O, Masin J, Genth H, Vojtova J, Linhartova I, Benada O, Just I, Sebo P. 2008. Adenylate cyclase toxin subverts phagocyte function by RhoA inhibition and unproductive ruffling. The Journal of Immunology 181:5587-5597. doi: 10.4049/jimmunol.181.8.5587.
37. Kant AM, De P, Peng X, Yi T, Rawlings DJ, Kim JS, Durden DL. 2002. SHP-1 regulates fcgamma receptor- mediated phagocytosis and the activation of RAC. Blood 100:1852-1859.
38. Karimova G, Pidoux J, Ullmann A, Ladant D. 1998. A bacterial two-hybrid system based on a reconstituted signal transduction pathway. Proceedings of the National Academy of Sciences 95:5752-5756. doi: 10.1073/pnas.95.10.5752.
39. Khelef N, Sakamoto H, Guiso N. 1992. Both adenylate cyclase and hemolytic activities are required by bordetella pertussis to initiate infection. Microbial Pathogenesis 12:227-235. doi: 10.1016/0882-4010(92)90057-U.
40. Kiefer F, Brumell J, Al-Alawi N, Latour S, Cheng A, Veillette A, Grinstein S, Pawson T. 1998. The syk protein tyrosine kinase is essential for fc receptor signaling in macrophages and neutrophilss. Molecular and Cellular Biology 18:4209-4220. doi: 10.1128/MCB.18.7.4209.
41. Kollman PA. 1996. Advances and continuing challenges in achieving realistic and predictive simulations of the properties of organic and biological molecules. Accounts of Chemical Research 29:461-469. doi: 10.1021/ar9500675.
42. Lenz DH, Weingart CL, Weiss AA. 2000. Phagocytosed bordetella pertussis fails to survive in human neutrophils. Infection and Immunity 68:956-959. doi: 10.1128/IAI.68.2.956-959.2000.
43. Li Y, Zhang L. 2003. The fourth blade within the -propeller is involved specifically in C3bi recognition by integrin m 2. Journal of Biological Chemistry 278:34395-34402. doi: 10.1074/jbc.M304190200.
44. Li N, Mao D, Lu S, Tong C, Zhang Y, Long M. 2013. Distinct binding affinities of mac-1 and LFA-1 in neutrophil activation. The Journal of Immunology 190:4371-4381. doi: 10.4049/jimmunol.1201374.
45. Lu C, Oxvig C, Springer TA. 1998. The structure of the -propeller domain and c-terminal region of the integrin m subunit: DEPENDENCE on SUBUNIT ASSOCIATION and PREDICTION of DOMAINS. Journal of Biological Chemistry 273:15138-15147. doi: 10.1074/jbc.273.24.15138.
46. Mazzone A, Ricevuti G. 1995. Leukocyte CD11/CD18 integrins: biological and clinical relevance. Haematologica 80:161-175.
47. Misegades LK, Winter K, Harriman K, Talarico J, Messonnier NE, Clark TA, Martin SW. 2012. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, california, 2010. JAMA 308:2126-2132. doi: 10.1001/jama.2012.14939.
48. Mócsai A, Zhou M, Meng F, Tybulewicz VL, Lowell CA. 2002. Syk is required for integrin signaling in neutrophils. Immunity 16:547-558. doi: 10.1016/S1074-7613(02)00303-5.
49. Mócsai A, Abram CL, Jakus Z, Hu Y, Lanier LL, Lowell CA. 2006. Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs. Nature Immunology 7:1326-1333. doi: 10.1038/ni1407.
50. Mócsai A, Ruland J, Tybulewicz VLJ. 2010. The SYK tyrosine kinase: a crucial player in diverse biological functions. Nature Reviews Immunology 10:387-402. doi: 10.1038/nri2765.
51. Morova J, Osicka R, Masin J, Sebo P. 2008. RTX cytotoxins recognize 2 integrin receptors through n-linked oligosaccharides. Proceedings of the National Academy of Sciences 105:5355-5360. doi: 10.1073/pnas.0711400105.
52. Njamkepo E, FranNo entityois D, Guiso N, Polla BS, Bachelet M. 2000. Adaptive responses of human monocytes infected byBordetella pertussis: the role of adenylate cyclase hemolysin. Journal of Cellular Physiology 183:91-99. doi: 10.1002/(SICI)1097-4652(200004)183:1<91::AID-JCP11>3.0.CO;2-S.
53. Octavia S, Sintchenko V, Gilbert GL, Lawrence A, Keil AD, Hogg G, Lan R. 2012. Newly emerging clones of bordetella pertussis carrying prn2 and ptxP3 alleles implicated in australian pertussis epidemic in 2008-2010. Journal of Infectious Diseases 205:1220-1224. doi: 10.1093/infdis/jis178.
54. Osicka R, Osicková A, Basar T, Guermonprez P, Rojas M, Leclerc C, Sebo P. 2000. Delivery of CD8(+) t-cell epitopes into major histocompatibility complex class i antigen presentation pathway by bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sites. Infection and Immunity 68:247-256.
55. Oxvig C, Springer TA. 1998. Experimental support for a -propeller domain in integrin -subunits and a calcium binding site on its lower surface. Proceedings of the National Academy of Sciences 95:4870-4875. doi: 10.1073/pnas.95.9.4870.
56. Paccani SR, Finetti F, Davi M, Patrussi L, D’Elios MM, Ladant D, Baldari CT. 2011. The bordetella pertussis adenylate cyclase toxin binds to t cells via LFA-1 and induces its disengagement from the immune synapse. Journal of Experimental Medicine 208:1317-1330. doi: 10.1084/jem.20101558.
57. Pearson RD, Symes P, Conboy M, Weiss AA, Hewlett EL. 1987. Inhibition of monocyte oxidative responses by bordetella pertussis adenylate cyclase toxin. Journal of Immunology 139:2749-2754.
58. Ross PJ, Lavelle EC, Mills KHG, Boyd AP. 2004. Adenylate cyclase toxin from bordetella pertussis synergizes withlipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory t cells. Infection and Immunity 72:1568-1579. doi: 10.1128/IAI.72.3.1568-1579.2004.
59. Rossi Paccani S, Benagiano M, Capitani N, Zornetta I, Ladant D, Montecucco C, D’Elios MM, Baldari CT. 2009. The adenylate cyclase toxins of bacillus anthracis and bordetella pertussis promote Th2 cell development by shaping t cell antigen receptor signaling. PLoS Pathogens 5:e1000325. doi: 10.1371/journal.ppat.1000325.
60. Roy A, Kucukural A, Zhang Y. 2010. I-TASSER: a unified platform for automated protein structure and function prediction. Nature Protocols 5:725-738. doi: 10.1038/nprot.2010.5.
61. Sanchez-Madrid F, Nagy JA, Robbins E, Simon P, Springer TA. 1983. A human leukocyte differentiation antigen family with distinct alpha- subunits and a common beta-subunit: the lymphocyte function-associated antigen (lFA-1), the C3bi complement receptor (oKM1/Mac-1), and the p150,95 molecule. Journal of Experimental Medicine 158:1785-1803. doi: 10.1084/jem.158.6.1785.
62. Schymeinsky J, Mócsai A, Walzog B. 2007. Neutrophil activation via beta2 integrins (cD11/CD18): molecular mechanisms and clinical implications. Thrombosis and Haemostasis 98:262-273.
63. Sebo P, Ladant D. 1993. Repeat sequences in the bordetella pertussis adenylate cyclase toxin can be recognized as alternative carboxy-proximal secretion signals by the escherichia coli alpha-haemolysin translocator. Molecular Microbiology 9:999-1009. doi: 10.1111/j.1365-2958.1993.tb01229.x.
64. Sebo P, Osicka R, Masin J. 2014. Adenylate cyclase toxin-hemolysin relevance for pertussis vaccines. Expert Review of Vaccines 13:1215-1227. doi: 10.1586/14760584.2014.944900.
65. Shi Y, Tohyama Y, Kadono T, He J, Miah SM, Hazama R, Tanaka C, Tohyama K, Yamamura H. 2006. Protein- tyrosine kinase syk is required for pathogen engulfment in complement-mediated phagocytosis. Blood 107:4554-4562. doi: 10.1182/blood-2005-09-3616.
66. Spensieri F, Fedele G, Fazio C, Nasso M, Stefanelli P, Mastrantonio P, Ausiello CM. 2006. Bordetella pertussis inhibition of interleukin-12 (iL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction. Infection and Immunity 74:2831-2838. doi: 10.1128/IAI.74.5.2831-2838.2006.
67. Springer TA. 1997. Folding of the n-terminal, ligand-binding region of integrin -subunits into a -propeller domain. Proceedings of the National Academy of Sciences 94:65-72. doi: 10.1073/pnas.94.1.65.
68. Tan SuetMien. 2012. The leucocyte b2 (cD18) integrins: the structure, functional regulation and signalling properties. Bioscience Reports 32:241-269. doi: 10.1042/BSR20110101.
69. Tartof SY, Lewis M, Kenyon C, White K, Osborn A, Liko J, Zell E, Martin S, Messonnier NE, Clark TA, Skoff TH. 2013. Waning immunity to pertussis following 5 doses of DTaP. PEDIATRICS 131:e1047-e1052. doi: 10.1542/peds.2012-1928.
70. Turner M, Schweighoffer E, Colucci F, Di Santo JP, Tybulewicz VL. 2000. Tyrosine kinase SYK: essential functions for immunoreceptor signalling. Immunology Today 21:148-154. doi: 10.1016/S0167-5699(99)01574-1.
71. Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJC. 2005. GROMACS: fast, flexible, and free. Journal of Computational Chemistry 26:1701-1718. doi: 10.1002/jcc.20291.
72. Van Ziffle JA, Lowell CA. 2009. Neutrophil-specific deletion of syk kinase results in reduced host defense to bacterial infection. Blood 114:4871-4882. doi: 10.1182/blood-2009-05-220806.
73. Van der Vieren M, Le Trong H, Wood CL, Moore PF, John TS, Staunton DE, Gallatin WM. 1995. A novel leukointegrin, adb2, binds preferentially to ICAM-3. Immunity 3:683-690. doi: 10.1016/1074-7613(95)90058-6.
74. Vang T, Torgersen KM, Sundvold V, Saxena M, Levy FO, Skalhegg BS, Hansson V, Mustelin T, Tasken K. 2001. Activation of the cooh-terminal src kinase (csk) by camp-dependent protein kinase inhibits signaling through the t cell receptor. Journal of Experimental Medicine 193:497-508. doi: 10.1084/jem.193.4.497.
75. Vojtova J, Kamanova J, Sebo P. 2006. Bordetella adenylate cyclase toxin: a swift saboteur of host defense. Current Opinion in Microbiology 9:69-75. doi: 10.1016/j.mib.2005.12.011.
76. Weingart CL, Mobberley-Schuman PS, Hewlett EL, Gray MC, Weiss AA. 2000. Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of bordetella pertussis by human neutrophils. Infection and Immunity 68:7152-7155. doi: 10.1128/IAI.68.12.7152-7155.2000.
77. Weiss AA, Hewlett EL, Myers GA, Falkow S. 1984. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of bordetella pertussis. Journal of Infectious Diseases 150:219-222. doi: 10.1093/infdis/150.2.219.
78. Willeke T, Schymeinsky J, Prange P, Zahler S, Walzog B. 2003. A role for syk-kinase in the control of the binding cycle of the 2 integrins (cD11/CD18) in human polymorphonuclear neutrophils. Journal of Leukocyte Biology 74:260-269. doi: 10.1189/jlb.0102016.
79. Witt MA, Katz PH, Witt DJ. 2012. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a north american outbreak. Clinical Infectious Diseases 54:1730-1735. doi: 10.1093/cid/cis287.
80. Witt MA, Arias L, Katz PH, Truong ET, Witt DJ. 2013. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort. Clinical Infectious Diseases 56:1248-1254. doi: 10.1093/cid/cit046.
81. Xie C, Shimaoka M, Xiao T, Schwab P, Klickstein LB, Springer TA. 2004. The integrin -subunit leg extends at a Ca2+-dependent epitope in the thigh/genu interface upon activation. Proceedings of the National Academy of Sciences 101:15422-15427. doi: 10.1073/pnas.0406680101.
82. Xie C, Zhu J, Chen X, Mi L, Nishida N, Springer TA. 2010. Structure of an integrin with an aI domain, complement receptor type 4. The EMBO Journal 29:666-679. doi: 10.1038/emboj.2009.367.
83. Yalamanchili P, Lu C, Oxvig C, Springer TA. 2000. Folding and function of i domain-deleted mac-1 and lymphocyte function-associated antigen-1. Journal of Biological Chemistry 275:21877-21882. doi: 10.1074/jbc.M908868199.